IEZZI, MANUELA
 Distribuzione geografica
Continente #
NA - Nord America 7.042
AS - Asia 4.752
EU - Europa 4.702
SA - Sud America 658
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 10
Totale 17.274
Nazione #
US - Stati Uniti d'America 6.906
SG - Singapore 1.927
CN - Cina 1.224
IT - Italia 859
IE - Irlanda 713
UA - Ucraina 609
BR - Brasile 540
RU - Federazione Russa 504
SE - Svezia 494
TR - Turchia 494
VN - Vietnam 464
GB - Regno Unito 448
DE - Germania 343
IN - India 330
FR - Francia 292
FI - Finlandia 162
CA - Canada 76
HK - Hong Kong 69
NL - Olanda 60
AR - Argentina 48
PL - Polonia 47
ZA - Sudafrica 42
CZ - Repubblica Ceca 39
MX - Messico 38
BD - Bangladesh 33
BE - Belgio 32
IQ - Iraq 32
ES - Italia 25
JP - Giappone 25
AT - Austria 24
KR - Corea 20
VE - Venezuela 18
IR - Iran 16
PK - Pakistan 15
SA - Arabia Saudita 15
EC - Ecuador 14
MA - Marocco 13
CO - Colombia 12
EU - Europa 12
ID - Indonesia 11
IL - Israele 11
AE - Emirati Arabi Uniti 10
KE - Kenya 10
RO - Romania 10
CL - Cile 8
EG - Egitto 8
GR - Grecia 8
AU - Australia 7
OM - Oman 7
PH - Filippine 7
BG - Bulgaria 6
CH - Svizzera 6
MY - Malesia 6
PY - Paraguay 6
TN - Tunisia 6
UZ - Uzbekistan 6
LT - Lituania 5
PE - Perù 5
PT - Portogallo 5
UY - Uruguay 5
AO - Angola 4
AZ - Azerbaigian 4
BZ - Belize 4
JM - Giamaica 4
JO - Giordania 4
KZ - Kazakistan 4
NP - Nepal 4
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
LB - Libano 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
TT - Trinidad e Tobago 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
DZ - Algeria 2
LA - Repubblica Popolare Democratica del Laos 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
GE - Georgia 1
GP - Guadalupe 1
HR - Croazia 1
LK - Sri Lanka 1
MD - Moldavia 1
ML - Mali 1
MT - Malta 1
MU - Mauritius 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
RS - Serbia 1
SC - Seychelles 1
Totale 17.271
Città #
Singapore 1.461
Chandler 896
San Jose 725
Jacksonville 704
Dublin 703
Ashburn 477
Beijing 350
Princeton 300
Dallas 291
Southend 286
Dearborn 233
Izmir 225
Nanjing 188
New York 174
Ann Arbor 155
Santa Clara 154
Ho Chi Minh City 150
Los Angeles 147
Altamura 134
Wilmington 134
Chieti 124
The Dalles 112
Cambridge 111
Boardman 98
Pescara 98
Hanoi 91
Tongling 78
Buffalo 64
São Paulo 64
Hong Kong 63
Nanchang 63
Munich 62
Council Bluffs 57
Moscow 56
Redondo Beach 56
Woodbridge 50
Warsaw 39
Orem 38
Brooklyn 36
Helsinki 36
Denver 35
Hebei 34
Grevenbroich 33
Johannesburg 33
Montreal 33
Washington 32
Chennai 31
Dong Ket 31
Nuremberg 31
Tianjin 31
Frankfurt am Main 30
Rome 30
Shenyang 29
Brno 28
Seattle 28
London 27
Atlanta 26
Hefei 26
Milan 26
Houston 25
Amsterdam 24
Brussels 24
Chicago 24
Kunming 24
Tokyo 24
Norwalk 23
Changsha 21
Ancona 20
Haiphong 20
Poplar 20
Seoul 20
Ankara 19
Da Nang 19
Turku 19
Augusta 18
Jiaxing 18
Mexico City 18
Rio de Janeiro 18
Toronto 18
Manchester 17
Stockholm 17
Baghdad 16
Boston 16
Castignano 16
Hangzhou 16
Jinan 16
San Mateo 16
Mumbai 15
Vienna 15
Lappeenranta 14
Orange 14
Pune 14
Falls Church 13
Guangzhou 13
Phoenix 13
Belo Horizonte 12
Biên Hòa 12
Camerino 12
Leawood 11
New Delhi 11
Totale 10.572
Nome #
ALK protein analysis by IHC staining after recent regulatory changes: A comparison of two widely used approaches, revision of the literature, and a new testing algorithm 212
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 195
EV20-mediated delivery of cytotoxic auristatin MMAF exhibits potent therapeutic efficacy in cutaneous melanoma 177
EV20-Sap, a novel anti-HER-3 antibody-drug conjugate, displays promising antitumor activity in melanoma 171
L’allergoide monomerico agisce anche sul GALT 170
A limited autoimmunity to p185neu elicited by DNA and allogeneic cell vaccine hampers the progression of preneoplastic lesions in HER-2/NEU transgenic mice. 166
Autoimmune B cell lymphopenia following successful adoptive therapy with telomerase-specific T lymphocytes. 165
CAR-T-Derived Extracellular Vesicles: A Promising Development of CAR-T Anti-Tumor Therapy 163
A DNA vaccine targeting angiomotin inhibits angiogenesis and suppresses tumor growth. 163
Xenogeneic immunization in mice using HER2 DNA delivered by an adenoviral vector. 158
Functional and prognostic significance of the genomic amplification of frizzled 6 (FZD6) in breast cancer 158
Activated d16HER2 homodimers and SRC kinase mediate optimal efficacy for trastuzumab. 155
Analytical assessment of MALDI-TOF Imaging Mass Spectrometry on thin histological samples. An insight in proteome investigation. 155
Enhanced expression of mir-181b in b cells of cll improves the anti-tumor cytotoxic t cell response 155
Feasibility of telomerase-specific adoptive T-cell therapy for B-cell chronic lymphocytic leukemia and solid malignancies 154
Anti-Thyroid Effect of Resveratrol 152
Antitumor immunization of mothers delays tumor development in cancer-prone offspring 151
Effective control of acute myeloid leukaemia and acute lymphoblastic leukaemia progression by telomerase specific adoptive T-cell therapy 149
Repurposing a psychoactive drug for children with cancer: p27 Kip1-dependent inhibition of metastatic neuroblastomas by Prozac 147
Blood Circulating CD133+ Extracellular Vesicles Predict Clinical Outcomes in Patients with Metastatic Colorectal Cancer 146
The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis. 145
Resveratrol has anti-thyroid effects both in vitro and in vivo 145
A Dietary Tomato Supplement Prevents Prostate Cancer in TRAMP Mice 143
An integrated approach of immunogenomics and bioinformatics to identify new Tumor Associated Antigens (TAA) for mammary cancer immunological prevention. 141
Inhibition of prostate carcinogenesis by combined active immunoprophylaxis 141
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 141
Class II phosphoinositide 3-kinase C2β regulates a novel signaling pathway involved in breast cancer progression 139
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 138
Effect of maternal exposure to endocrine disrupting chemicals on reproduction and mammary gland development in female sprague-dawley rats. 137
Effects of chronic hypoxia and cobalt on macroprotein pattern in the rabbit carotid body and superior cervical ganglion: preliminary observations. 137
A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins. 136
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 136
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 136
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 135
A DNA Vaccine against ERBB2 Impairs Chemical Carcinogenesis in Random-Bred Hamsters. 134
Preventive Vaccination with Telomerase Controls Tumor Growth in Genetically Engineered and Carcinogen-Induced Mouse Models of Cancer. 132
Reversal of P-glycoprotein-mediated multidrug resi stance in human sarcoma MES-SA/Dx-5 cells by nonsteroidal anti-inflammatory drugs 132
Quercetin increases Major Histocompatibility Complex (MHC) class I expression in thyroid cells 132
EFFECTS OF HYPERBARIC OXYGEN EXPOSURE ON MOBILIZATION OF ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS 131
Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor 131
Dramatic response to crizotinib in ROS1 fluorescent in situ hybridization- and immunohistochemistry-positive lung adenocarcinoma: a case series. 130
Cure of mammary carcinomas in Her-2 transgenic mice through sequential stimulation of innate (neoadjuvant interleukin-12) and adaptive (DNA vaccine electroporation) immunity. 130
HCG hastens both the development of mammary carcinoma and the metastatization of HCG/LH and ERBB-2 receptor-positive cells in mice. 130
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 129
Sorafenib's inhibition of prostate cancer growth in transgenic adenocarcinoma mouse prostate mice and its differential effects on endothelial and pericyte growth during tumor angiogenesis. 129
PLC-gamma-1 phosphorylation status is prognostic of metastatic risk in patients with early-stage Luminal-A and -B breast cancer subtypes 129
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 129
Salivary carcinoma in HER-2/neu transgenic male mice: an angiogenic switch is not required for tumor onset and progression 128
Protective immunity against neu-positive carcinomas elicited by electroporation of plasmids encoding decreasing fragments of rat neu extracellular domain. 128
Electroporated DNA Vaccine Clears Away Multifocal Mammary Carcinomas in Her-2/neu Transgenic Mice 128
Sanguinarine suppresses basal-like breast cancer growth through dihydrofolate reductase inhibition. 127
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 127
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 126
Effects of castration on the development of prostate adenocarcinoma from its precursor HGPIN and on the occurrence of androgen-independent poorly differentiated carcinoma in TRAMP mice. 125
null 125
Targeting vesicular lgals3bp by an antibody-drug conjugate as novel therapeutic strategy for neuroblastoma 124
AvidinOX for highly efficient tissue-pretargeted radionuclide therapy. 123
Phage-Based Anti-HER2 Vaccination Can Circumvent Immune Tolerance against Breast Cancer 123
MiR-205-5p inhibition by locked nucleic acids impairs metastatic potential of breast cancer cells 123
A multi-DNA preventive vaccine for p53/Neu driven cancer syndrome. 120
Tamoxifen combined to anti-HER-2/neu cell vaccine does not hamper cancer immunopreventive efficacy. 120
Effects of ELF-EMF exposure on haemopoiesis and mammary carcinogenesis in BALB/c mice 119
The non-inflammatory role of C1q during Her2/neu-driven mammary carcinogenesis 119
A vaccine targeting angiomotin induces an antibody response which alters tumor vessel permeability and hampers the growth of established tumors. 118
BALB-neuT Female Mice as a Dynamic Model of Mammary Cancer 117
Antimetastatic activity of a preventive cancer vaccine. 116
Neutrophils in anti-cancer immunological strategies: old players in new games 116
Expression of CREB in Primary Pterygium and Correlation with Cyclin D1, ki-67, MMP7, p53, p63, Survivin and Vimentin. 116
HER-2/neu mediates oncogenic transformation via altered CREB expression and function. 115
Multiple roles of perforin in hampering ERBB-2 (Her-2/neu) carcinogenesis in transgenic male mice 115
Monomeric allergoid intragastric administration induces local and systemic tolerogenic response involving IL-10-producing CD4(+)CD25(+) T regulatory cells in mice. 115
The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries 114
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 114
The adjuvant activity of BAT antibody enables DNA vaccination to inhibit the progression of established autochthonous Her-2/neu carcinomas in BALB/c mice. 113
p130Cas is an essential transducer element in ErbB2 transformation. 113
The water soluble ruthenium(II) organometallic compound [Ru(p-cymene)(bis(3,5 dimethylpyrazol-1-yl)methane)Cl]Cl suppresses triple negative breast cancer growth by inhibiting tumor infiltration of regulatory T cells 113
The 2EF Antibody Targets a Unique N-Terminal Epitope of Trop-2 and Enhances the In Vivo Activity of the Cancer-Selective 2G10 Antibody 111
Timely DNA vaccine combined with systemic IL-12 prevents parotid carcinomas before a dominant-negative p53 makes their growth independent of HER-2/neu expression. 111
Effect of acute and chronic cobalt administration on carotid body chemoreceptors responses. 111
Stem Cell Emergence After HBO In Volunteers 111
LAG-3 enables DNA vaccination to persistently prevent mammary carcinogenesis in HER-2/neu transgenic BALB/c mice. 111
Disruption of IFN-I signaling promotes HER2/neu tumor progression and breast cancer stem cells 110
Intradermal DNA Electroporation Induces Cellular and Humoral Immune Response and Confers Protection against HER2/neu Tumor 110
rBet v 1 immunotherapy of sensitized mice with Streptococcus thermophilus as vehicle and adjuvant. 109
Irreversible inhibition of Δ16HER2 is necessary to suppress Δ16HER2-positive breast carcinomas resistant to Lapatinib 109
Lack of expression of galectin-3 is associated with a poor outcome in node-negative patients with laryngeal squamous-cell carcinoma. 108
Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. 108
Phospholipase Cgamma1 is required for metastasis development and progression 108
Arginase 1-based immune modulatory vaccines induce anti-cancer immunity and synergize with anti-PD-1 checkpoint blockade 108
Immunoprevention of mammary carcinoma in HER-2/neu transgenic mice is IFN-gamma and B cell dependent. 107
Computational drugs repositioning identifies inhibitors of oncogenic PI3K/AKT/P70S6K-dependent pathways among FDAapproved compounds 107
Cutting Edge: TRAIL Deficiency Accelerates Hematological Malignancies. 106
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway. 106
Immunoprevention of HER-2/neu transgenic mammary carcinoma through an interleukin 12-engineered allogeneic cell vaccine. 105
Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. 105
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response 103
Predictive signatures inform the effective repurposing of Decitabine to treat K-RAS-dependent Pancreatic Ductal Adenocarcinoma 103
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 101
Generation of multiparametric MRI maps by using Gd-labelled-RBCs reveals phenotypes and stages of murine prostate cancer 101
Disabled Homolog 2 Controls Prometastatic Activity of Tumor-Associated Macrophages 101
Totale 12.960
Categoria #
all - tutte 67.668
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.668


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021270 0 0 0 0 0 0 0 0 0 115 90 65
2021/2022708 14 14 14 120 53 12 26 60 55 50 83 207
2022/20232.468 184 362 156 280 272 471 127 168 285 32 63 68
2023/20241.158 78 54 68 51 61 346 270 66 14 28 13 109
2024/20252.929 173 490 388 102 94 136 205 194 294 130 325 398
2025/20265.697 491 257 574 786 651 416 1.077 360 656 429 0 0
Totale 17.840